Stegent Equity Advisors, Inc. Johnson & Johnson Transaction History

Stegent Equity Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	SELL	$151.05 - $180.26 $30,058 - $35,871	-199 Reduced 13.07%	1,324 $205,000
Q2 2022 Aug 10, 2022	SELL	$168.19 - $186.01 $45,915 - $50,780	-273 Reduced 15.2%	1,523 $269,000
Q1 2022 Apr 25, 2022	SELL	$158.14 - $179.59 $31,944 - $36,277	-202 Reduced 10.11%	1,796 $318,000
Q4 2021 Feb 08, 2022	BUY	$155.93 - $173.01 $311,548 - $345,673	1,998 New	1,998 $342,000

4,272

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Stegent Equity Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Stegent Equity Advisors, Inc. with notifications on news.